当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第16期
编号:13372271
放疗加紫杉醇周疗在局部晚期宫颈癌中的临床应用(4)
http://www.100md.com 2019年6月5日 《中国现代医生》 2019年第16期
     [16] Monk BJ,Sill MW,McMeekin DS,et al. Phase Ⅲ trial of four cisplatin-containing doublet combinations in stage IVB,recurrent,or persistent cervical carcinoma:A gynecologic oncology group study[J]. J Clin Oncol,2009,27(28):4649-4655.

    [17] Walker JL,Morrison A,DiSilvestro P,et al. A phase Ⅰ/Ⅱ study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes:A gynecologic oncology group study[J]. Gynecol Oncol,2009,112(1):78-84.

    [18] Kim K,Chie EK,Wu HG,et al. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer[J]. Gynecol Oncol,2006,101(3):398-402.

    [19] Wang X,Shen Y,Zhao Y, et al. Adjuvant intensity-modulated radiotherapy(IMRT) with concurrent paclitaxel and cisplatin in cervical cancer patients with high risk factors:A phase II trial[J]. Eur J Surg Oncol,2015,41(8):1082-1088.

    [20] Wang W,Hou X,Yan J,et al. Outcome and toxicity of radical radiotherapy or concurrent chemoradiotherapy for elderly cervical cancer women[J]. BMC Cancer,2017,17(1):510.

    [21] 劉鑫丽,姚秀英,李世春,等. 顺铂同步放化疗与单纯放疗治疗中晚期宫颈癌疗效比较[J]. 山东医药,2014,(44):81-82.

    (收稿日期:2018-11-18), 百拇医药(谢优优 陈星 吴素芳 杨海华)
上一页1 2 3 4